Heparin-like anticoagulants and pregnancy. Description of a clinical case;Fattori heparin-like e gravidanza: Descrizione di un caso clinico

Minerva Ginecologica

Volumn 50, Issue 10, 1998, Pages 435-440

  Cassese, E ^a,b   Piscitelli, V ^a   Di Grazia, F ^a   Di Prisco, L ^a   Balbi, C ^a   Balbi, G C ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Circulating heparin like anticoagulant; Heparin; Pregnancy

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CASE REPORT; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; HUMAN; PARITY; PREGNANCY; PREGNANCY OUTCOME;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION TESTS; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; HEPARIN; HUMANS; PARITY; PREGNANCY; PREGNANCY OUTCOME;

EID: 0032177947     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Khoory MS, Neshein ME, Bowie EJW, Mann KG, Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. J Clin Invest 1980;65:666.
2. Palmer RN, Rick ME, Rick PD, Zeller JA, Granlick HR, Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med 1984;310:L1096.
3. Chapman GS, George CB, Danley DL. Heparin-like anticoagulant associated with plasma cell myeloma. Am J Clin Pathol 1985;83:764.
4. Kaufman PA, Gockerman JP, Greenberg CS. Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature. Am J Med 1989;86:612.
5. Bussel JB, Steinherz PG, Miller DR, Hilgartner MW. A heparin-like anticoagulant in an 8-month-old boy with acute monoplastic leukemia. AmJ Hematol 1984;16:83.
6. Nenci GG. Berrettini M, Parise P, Agnelli G. Persistent spontaneous heparinemia in systemic mastocytosis. Folia Haematol 1982;109:453.
7. Watts E, Chisholm M, Smith AG. Circulating heparin-like anticoagulants (letter). N Engl J Med 1984;311:1055.
8. Rodgers GM, Corash L. Acquired heparin-like anticoagulant in a patient with metastatic breast carcinoma. West J Med 1985;143:672.
9. Tefferi A, Owen BA, Nichols WL, Witzig TE, Owen WG. Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma. Blood 1989;74:252.
10. Peden JC, McFarland JA. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracoporeal circulation. Blood 1959;14:1230.
11. Jaques LB. Protamine-antagonist to heparin. Can Med Assoc J 1973;108:1291-7.
12. Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulfate proteoglycans. Biochem J 1986;236:315-25.
13. Hubbard AR, Jennings CA. Neutralisation of heparan sulfate and low molecular weight heparin by protamine. Thromb Haemost 1985,53:86-9.
14. Felix K. Protamines. In: Anfinsen CB, Anson ML, Bailey K, Edsall JT, editors. Advances in Protein Chemistry. New York: Academic Press, 1960:1.
15. Rosenberg RD. The heparin-antithrombin-system: a natural anticoagulant mechanism. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemastasis and Thrombosis," 2nd Edition. Philadelphia: JB Lippincott Co, 1987:1373.
16. Home MK, Stein CA, La Rocca RV, Myers CE. Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 1988;71:273.
17. Home MK, Chao ES, Wilson OJ. Heparin-like anticoagulant associated with systemic candidiasis. Am J Hematol 1990;35:37-42.